Key Takeaways
- A one-off quarter, not a reset: Consolidated revenue fell 10% (domestic down 15%) as a GST rate cut triggered temporary trade destocking and a high summer base amplified the optics. Management calls it a write-off quarter and points to a healthy October rebound.
- GST disruption is already reversing: The 4% GST-driven destocking is expected to be fully recovered in Q3, with recovery visible in October and early November.
- Kesh King bets on science to reclaim relevance: The flagship hair oil has been losing ground to science-packed D2C brands. The response is a full repositioning to "Ayurveda plus science" with clinically proven claims, new packaging, and a big ad campaign.
- Strategic investments are the growth engine: This basket (Brillare, TMC) grew 16% YoY and 36% sequentially, driven by influencer flywheels and quick-commerce gains, and is expected to accelerate further in H2.
- What to watch next quarter: Whether the October rebound sustains through winter, the early consumer response to Kesh King Gold, and if the promised margin expansion materializes after the Q2 trough.
The GST Shock and Recovery
- What hit the quarter: The government cut GST rates across key FMCG categories in September. Trade channels and consumers deferred purchases in anticipation of lower MRPs, while distributors focused on liquidating higher-cost inventory. Emami passed on the benefit swiftly, but the disruption was sharp.
- The summer portfolio amplified the pain: The company had recorded its highest-ever Q2 sales for talc and prickly heat powder last year. Roughly 4-4.5% of domestic revenue was lost in the summer portfolio alone, a seasonal hit that cannot be recovered within the quarter.
- Domestic volumes fell ~16%: Management attributes the decline entirely to the GST transition and the high base, calling it a one-off quarter with multiple coinciding factors.
- The rebound is underway: October witnessed a healthy rebound in trade sentiments, with deferred winter loading being recovered. The first ten days of November continued the trend. Management is very confident the GST-driven destocking will be fully recovered in Q3.
Mohan Goenka: "I'm just being a little conservative, Arnab, because winter, as I said, has started with a very fine note, but it's yet to get into the winter season, okay? But you are right, I'm confident of double digit, not that I'm not. If the winter goes on like this, then nothing can stop for double digit for sure."
Kesh King: The Big Repositioning Bet
- The problem: Kesh King, a pure Ayurvedic hair oil, faced significant challenge from D2C brands that are science-packed, a positioning that resonates with young consumers and reflects where the category trend is moving.
- The research finding: After 9-10 months of consumer research, management concluded that Ayurveda is still relevant but needed to be backed by clinical efficacy to compete.
- The relaunch: Kesh King has been relaunched as Kesh King Gold with an evolved "Ayurveda plus science" proposition. The formulation was upgraded with Gro Biotin and plant Omega 369, ingredients management describes as scientifically proven to enhance results. Every product is now clinically tested with clinically proven claims.
- The go-to-market push: The relaunch is supported by a 360-degree plan: new communication, new packaging, an influencer flywheel, and a large advertising campaign.
Mohan Goenka: "I think this was a very important move because Kesh King faced significantly challenge from the D2C brands, particularly for hair fall categories, okay? And most of the D2C brands are science packed. So that is the need of the young consumers. That is where the trend is going."
Strategic Investments and Channel Shifts
- Strategic investments delivered standout growth: This portfolio, driven by increased investments behind Brillare and TMC brands, grew 16% YoY and 36% sequentially. Management expects an even higher growth rate in H2, in strong double digits.
- The influencer flywheel is working: New influencer strategies are taking effect and driving the acceleration.
- Channel mix is shifting: Gains are concentrated in quick commerce, modern trade, and the company's own D2C websites. Marketplaces also delivered strong growth but were held back by GST disruption at one large player whose warehouses were choked.
- Smart and Handsome expands its range: Twelve new products were launched across different categories this quarter, with an encouraging initial rollout across modern trade and e-commerce. The range is currently in test marketing on one e-commerce platform and will roll out to others and modern trade.
- On the structural shift in male grooming: Management acknowledged a structural shift away from face cream demand, which is why bold steps like category expansion are being taken. The new Smart and Handsome products sit at different price points and categories, so they will not compete with TMC.
Mohan Goenka: "Not really. These are absolutely at different price points and different categories altogether. It will not compete with the TMC. Definitely, yes, there is a structural shift that's why such bold steps are being taken. Face cream demand is not as high as it used to be."
International and Healthcare
- International business held steady: Delivered 8% growth despite persistent macro and geopolitical headwinds. SAARC markets, including Bangladesh, delivered over 22% growth. GCC/MENA was flattish, primarily due to Egypt where the company could not do much, and issues persist in Egypt and Bahrain.
- Healthcare showed pockets of strength: The Medico business, which serves Ayurvedic and other doctor segments, grew well. Focused brands like cough syrups, honey, and the D2C site Zandu Care also performed. Initiatives are underway to scale the Chyawanprash range and other focus categories.
- International outlook is cautiously hopeful: Management hopes for better improvements in coming quarters across most geographies, supported by many new product developments being built for the future portfolio.
Margins and Profitability
- Gross margins held firm: Gross margin remained stable at 71%, underscoring cost discipline and input price stability even as the top line contracted sharply.
- Operating leverage reversed temporarily: EBITDA fell 29% and PAT fell 30%, a direct reflection of the lower top line rather than any structural cost problem.
- Q3 margin expansion promised: Management expects margin expansion and high growth in EBITDA and net margins in Q3, stating explicitly that Q2 can be written off.
- Price-action question left open: When asked whether the company would consider rolling back prices or taking them higher if consumers do not respond to lower prices with higher volumes in the next 2-4 quarters, management declined to answer, saying it is too early to decide.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| GST destocking recovery | 4% GST-driven destocking to be fully recovered | Q3 FY26 |
| Strategic investments growth | Growth rate to accelerate to strong double digits, higher than H1 | H2 FY26 |
| Margin recovery | Margin expansion, high growth in EBITDA and net margins expected | Q3 FY26 |
| Kesh King Gold relaunch | Backed by a huge advertising campaign | Underway (launched last month) |
| Smart and Handsome rollout | Range to be rolled out to other e-commerce sites and modern trade | No date (test marketing stage) |
| FY27 outlook | Should definitely be much better than FY26, starting with a lower summer base and strengthened pillars | FY27 |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Consolidated revenue | ₹799 cr, declined 10% YoY |
| Domestic business revenue | Declined 15% YoY |
| Domestic volume decline | ~16% YoY |
| Gross margin | 71%, stable YoY |
| EBITDA | ₹179 cr, declined 29% YoY |
| PAT | ₹148 cr, declined 30% YoY |
| Interim dividend | ₹4 per share (400%), declared for FY26 |
| International business growth | 8% YoY primary sale growth |
| Strategic investments portfolio growth | 16% YoY, 36% sequential |
| Honey growth | 36% YoY |
| Zandu Care growth | 17% YoY |
| Medico business growth | ~8% YoY |
| SAARC markets growth | Over 22% YoY, including Bangladesh |
| Nepal growth | Almost 100% YoY |
| Quick commerce saliency | ~14% of e-com, ~11% of domestic consumer business |
| Portfolio with grammage increase post-GST | 20% of portfolio (sachets), balance reduced MRP |
| MRP reduction across domestic portfolio | ~₹250–260 cr |
| Core domestic portfolio benefiting from GST cut | 88% of portfolio |
| Total portfolio at 5% GST rate | ~93% |